AI assistant
IMPEDIMED LIMITED — Capital/Financing Update 2010
Mar 31, 2010
65135_rns_2010-03-31_e142c7a5-75d5-4951-8cbb-99945800dae5.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [90 x 80] intentionally omitted <==
ImpediMed Limited
ABN 65 089 705 144
1 April 2010
The Manager Company Announcements Office ASX Limited
Unit 1 50 Parker Court Pinkenba QLD 4113
Tel: +61 7 3860 3700 Fax: +61 7 3260 1225 Email: [email protected]
IMPEDIMED LIMITED NOTICE UNDER SECTION 708AA(2)(f) CORPORATIONS ACT 2001 (CTH)
ImpediMed Limited ABN 65 089 705 144 ( ImpediMed ) has announced a non-renounceable pro-rata entitlement offer of 1 fully paid ordinary share ( New Shares ) for every 8 ImpediMed ordinary shares held as at 7.00pm (Sydney time) on the record date of 15 April 2010 by shareholders with registered addresses in Australia and New Zealand.
This notice is given to ASX under paragraph 708AA(2)(f) Corporations Act 2001 ( Corporations Act ) as modified by Australian Securities & Investments Commission class order CO 08/35.
-
1 ImpediMed will offer the New Shares for issue without disclosure to investors under Part 6D.2 of the Corporations Act.
-
2 As at the date of this notice ImpediMed has complied with the provisions of:
-
(a) Chapter 2M of the Corporations Act as they apply to ImpediMed; and
-
(b) section 674 of the Corporations Act.
-
-
3 As at the date of this notice there is no excluded information within the meaning of sections 708AA(8) and 708AA(9) of the Corporations Act which is required to be disclosed by ImpediMed.
-
4 The issue of the New Shares is not expected to have any material effect or consequence on the control of ImpediMed.
Signed for ImpediMed Limited by
==> picture [107 x 48] intentionally omitted <==
Steve Denaro Company Secretary
S u r v i v i n g c a n c e r w i t h o u t c o m p r o m i s i n g l i f e s t y l e